Musclepharm (MSLP) Annual Balance Sheets

Annual · GAAP · USD millions
Access MSLP quarterly Balance Sheets →
This balance sheet overview for Musclepharm spans from Dec 31 2016 to Dec 31 2021, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2021)
(Dec 31 2020) (Dec 31 2019) (Dec 31 2017) (Dec 31 2016)
Assets
Cash & cash equivalent1.22
Cash & Short-term Investments1.00
Accounts receivable6.39
Inventories1.83
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.53
Total Current Assets10.97
Equipment/Property/Plant Net0.01
Intangible Assets0.04
Other Assets, Noncurrent0.20
Total Assets11.21
Liabilities
Accounts Payable, Current AC17.98
Accrued Liabilities And Other Liabilities5.94
Short-term Debt5.04
Other Liabilities, Current12.12
Total Current Liabilities41.08
Other Long-term Debt, Noncurrent OT2.33
Convertible Notes Payable, Noncurrent LO0.00
Total Long-term Debt2.33
Financial Instruments, Insurance, Noncurrent0.00
Other liabilities, Noncurrent0.00
Accounts Payables And Accrued Liabilities0.34
Total Liabilities43.40
Stockholders' Equity
Common Stock Value0.03
Treasury Stock Value0.00
Additional Paid In Capital Common Stock183.36
Retained Earnings / Accumulated Deficit-205.54
Other Equity-10.04
Common Stockholder's Equity-32.19
Total Stockholder's Equity-32.19
Liabilities & Stockholder's Equity11.21
4 historic quarters locked

Sign in to unlock the full Musclepharm balance sheet history.

About Musclepharm Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-22-013900

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.